Androgen receptor protein levels are significantly reduced in serous ovarian carcinomas compared with benign or borderline disease but are not altered by cancer stage or metastatic progression.

Abstract

The androgen receptor (AR) is expressed in a majority of ovarian carcinomas, but its role in disease development remains unclear. In this study, AR and a novel AR molecular chaperone called small glutamine-rich tetratricopeptide repeat-containing protein alpha (SGTA) were investigated to assess their potential role in ovarian carcinogenesis. First, an AR… (More)
DOI: 10.1007/s12672-013-0135-0

Topics

6 Figures and Tables

Statistics

02040201520162017
Citations per Year

Citation Velocity: 8

Averaging 8 citations per year over the last 3 years.

Learn more about how we calculate this metric in our FAQ.

Cite this paper

@article{Butler2013AndrogenRP, title={Androgen receptor protein levels are significantly reduced in serous ovarian carcinomas compared with benign or borderline disease but are not altered by cancer stage or metastatic progression.}, author={Miriam S. Butler and Carmela Ricciardelli and Wayne D. Tilley and Theresa E Hickey}, journal={Hormones & cancer}, year={2013}, volume={4 3}, pages={154-64} }